Xiaojuan Zhang

EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression

Shunli Peng, Rong Wang, Xiaojuan Zhang et al. · Molecular Cancer · 2019 · 320 citations · Full text

Medicine, Oncology, Pharmacology +17

Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations

Huijuan Wang, Ziqi Wang, Guowei Zhang et al. · Cancer Medicine · 2019 · 75 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Comparable outcomes of nivolumab in patients with advanced NSCLC presenting with or without brain metastases: a retrospective cohort study

Guowei Zhang, Ruirui Cheng, Huijuan Wang et al. · Cancer Immunology Immunotherapy · 2020 · 51 citations · Full text

Medicine, Neurology, Oncology +13

Analysis of Biomarkers for Congenital Heart Disease Based on Maternal Amniotic Fluid Metabolomics

Yahong Li, Yun Sun, Lan Yang et al. · Frontiers in Cardiovascular Medicine · 2021 · 39 citations · Full text

Life Sciences, Maternal Health, Obstetrics +16

Efficacy and long-term survival of advanced lung adenocarcinoma patients with uncommon EGFR mutations treated with 1st generation EGFR-TKIs compared with chemotherapy as first-line therapy

Haixia Li, Chenyu Wang, Ziqi Wang et al. · Lung Cancer · 2019 · 28 citations

Medicine, Oncology, Pharmacology +12